www.aging-us.com AGING 2019, Vol. 11, No. 21 Review Emerging roles of piRNAs in cancer: challenges and prospects Ye Cheng1,2,*, Qian Wang2,*, Wei Jiang2,*, Yonghua Bian1, Yang zhou1, Anxing Gou1, Wenling Zhang3, Kai Fu2, Weihong Shi1 1Jiangsu Research Center for Primary Health Development and General Practice Education, Jiangsu Vocational College of Medicine, Yancheng, China 2Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China 3Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China *Co-first authors Correspondence to: Wenling Zhang, Kai Fu, Weihong Shi; email:
[email protected],
[email protected],
[email protected] Keywords: piRNA, PIWI proteins, cancer, transposon silencing Received: July 10, 2019 Accepted: October 28, 2019 Published: November 13, 2019 Copyright: Cheng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT PiRNAs are a small class of non-coding small RNAs newly discovered in recent years. Millions of piRNAs have been discovered to date, and more than 20,000 piRNA genes have been found in the human genome. Due to the relatively small number of studies related to piRNA, our understanding of piRNAs is very limited. Currently, the clear biological function of piRNAs is transposon mobilization inhibition by promoting transcript degradation and regulating chromatin formation. In addition, piRNAs can form piRNA-PIWI protein complexes with some members of the PIWI branch of the Argonaute protein. Based on these biological functions, piRNAs and PIWI proteins are important in maintaining the genomic integrity of germline cells.